Johnston Lloyd P.

CIK 00016769051 companyWATERTOWN, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001676905

Recent Transactions

46 trades

Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2023-01-05$1.13/sh−3,372→ 265,535 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2023-01-05$1.11/sh−20→ 265,515 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2023-01-04$1.13/sh−6,381→ 268,918 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2023-01-04$1.14/sh−11→ 268,907 total
Award
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2023-01-02+100,000→ 275,299 total
Award
Cartesian Therapeutics, Inc.$RNAC
Employee Stock Option (right to buy)
2023-01-02+475,000→ 475,000 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2022-01-05$3.09/sh−3,416→ 175,299 total
Award
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2022-01-03+72,000→ 178,715 total
Award
Cartesian Therapeutics, Inc.$RNAC
Employee Stock Option (right to buy)
2022-01-03+340,000→ 340,000 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2021-12-10$2.99/sh−4,370→ 106,715 total
Award
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2021-12-08+13,750→ 111,085 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2021-10-13$4.39/sh−3,892→ 97,335 total
Award
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2021-10-01+13,750→ 101,227 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2021-03-17$4.45/sh−15,128→ 87,477 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2021-02-11$0.63/sh+44,871→ 102,605 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Employee Stock Option (right to buy)
2021-02-11−44,871→ 0 total
Award
Cartesian Therapeutics, Inc.$RNAC
Employee Stock Option (right to buy)
2021-01-04+230,000→ 230,000 total
Award
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2021-01-04+38,000→ 57,734 total
Award
Cartesian Therapeutics, Inc.$RNAC
Employee Stock Option (right to buy)
2020-07-01+40,000→ 40,000 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2020-01-16$0.47/sh+5,128→ 16,734 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Employee Stock Option (right to buy)
2020-01-16−5,128→ 0 total
Award
Cartesian Therapeutics, Inc.$RNAC
Employee Stock Option (right to buy)
2020-01-02+140,000→ 140,000 total
Award
Cartesian Therapeutics, Inc.$RNAC
Employee Stock Option (right to buy)
2019-10-07+180,000→ 180,000 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2019-07-23$0.47/sh+10,000→ 11,606 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Employee Stock Option (right to buy)
2019-07-23−10,000→ 0 total
Award
Cartesian Therapeutics, Inc.$RNAC
Employee Stock Option (right to buy)
2019-01-07$2.60/sh+100,000→ 100,000 total
Award
Cartesian Therapeutics, Inc.$RNAC
Stock Option (Right to Buy)
2018-06-15+50,000→ 50,000 total
Award
Cartesian Therapeutics, Inc.$RNAC
Stock Option (Right to Buy)
2017-07-07+45,000→ 45,000 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Employee Stock Option (right to buy)
2017-07-03−5,959→ 126 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2017-07-03$2.77/sh+5,959→ 7,565 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2017-07-03$19.74/sh−100→ 7,465 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2017-07-03$19.09/sh−5,859→ 1,606 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Employee Stock Option (right to buy)
2017-06-15−10,512→ 10,000 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2017-06-15$17.04/sh−10,512→ 1,606 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2017-06-15$0.47/sh+20,512→ 22,118 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2017-06-15$17.00/sh−20,512→ 1,606 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Employee Stock Option (right to buy)
2017-06-15−20,512→ 0 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2017-06-15$0.47/sh+10,512→ 12,118 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Employee Stock Option (right to buy)
2017-04-17−13,205→ 0 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2017-04-17$13.95/sh−13,205→ 1,606 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2017-04-17$0.39/sh+13,205→ 14,811 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2017-01-23$13.95/sh−11,110→ 5,496 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2017-01-23$0.39/sh+15,000→ 16,606 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Employee Stock Option (right to buy)
2017-01-23−15,000→ 13,205 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2017-01-23$14.17/sh−3,890→ 1,606 total
Award
Cartesian Therapeutics, Inc.$RNAC
Employee Stock Option (right to buy)
2016-06-21+27,617→ 27,617 total

Companies

Cartesian Therapeutics, Inc.
COO and SVP, R&D
$RNAC

Recent Filings

Address

C/O SELECTA BIOSCIENCES, INC. 480 ARSENAL STREET, BUILDING ONE

WATERTOWN, MA, 02472

View on SEC.gov